STOCK TITAN

Sky Centy Invt (SKYID) Stock Price, News & Analysis

SKYID OTC
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
3 5 sessions, February 2, 2026 to February 25, 2026
Largest daily move
+110% close of February 25, 2026

Company Description

Sky Centy Invt (OTC: SKYID) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector.

SKYID gained 110.0% in the week to February 25, 2026. The last closing price was $0.2100.

For FY2025, Sky Centy Invt reported revenue of $76K with net income of -$117K.

This page collects what Stock Titan holds for SKYID, including price data, SEC filings, financial highlights, and short interest trends.

Stock Performance

$0.2100
No recent trading
Last close: February 25, 2026
+110%
1 week to February 25, 2026

Sky Centy Invt (SKYID) closed at $0.2100 on February 25, 2026. In the week to February 25, 2026, the price gained 110.0%.

See what a $1,000 investment in SKYID would be worth today

Average down calculator for SKYID

SKYID Metrics & Rankings

Price returns through February 25, 2026. Ranking links may use different dates.

Latest News

No recent news available for SKYID.

SEC Filings

Sky Centy Invt has filed 2 recent SEC filings, including 1 Form 10-Q, 1 Form 8-K. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all SKYID SEC filings →

Financial Highlights

Sky Centy Invt generated $76K in revenue in FY2025, retaining a 32.1% gross margin, operating income reached -$117K, and net income was -$117K. The company generated $46K in operating cash flow. The current ratio was 0.01, measuring current assets divided by current liabilities.

$76K
Revenue (FY2025)
-$117K
Net Income (FY2025)
$46K
Operating Cash Flow
$24K
Gross Profit (FY2025)

Upcoming Events

No upcoming events scheduled for SKYID.

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

SKYID Company Profile & Sector Positioning

Sky Centy Invt (SKYID) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.

Investors comparing SKYID often look at related companies in the same sector, including Merck KGaA (MKGAF), Merck KGaA (MKKGY), Takeda Pharm Co Ltd (TKPHF), Galderma Group AG (GALDY), and Galderma Group AG (GDERF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate SKYID's relative position within its industry.

Frequently Asked Questions

Sky Centy Invt (SKYID) has no recent trading. Its last close was $0.2100 on February 25, 2026.

The FY2025 revenue of Sky Centy Invt (SKYID) is $76K, from its most recent completed fiscal year.

The FY2025 net income of Sky Centy Invt (SKYID) is -$117K, from its most recent completed fiscal year.

The operating cash flow of Sky Centy Invt (SKYID) is $46K for FY2025, its most recent completed fiscal year. Learn about cash flow.

The gross profit margin of Sky Centy Invt (SKYID) is 32.1% for FY2025, its most recent completed fiscal year. Learn about gross margins.

The current ratio of Sky Centy Invt (SKYID), current assets divided by current liabilities, was 0.01 at the end of FY2025, its most recent completed fiscal year. Learn about liquidity ratios.

The gross profit of Sky Centy Invt (SKYID) is $24K for FY2025, its most recent completed fiscal year.

The operating income of Sky Centy Invt (SKYID) is -$117K for FY2025, its most recent completed fiscal year. Learn about operating income.